Status:
COMPLETED
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Genzyme, a Sanofi Company
Conditions:
Kidney Transplant
Eligibility:
All Genders
18-70 years
Brief Summary
This study is being done to collect blood and bone marrow samples for biologic studies of antibody producing cells. Donor specific antibodies can cause damage to the kidneys after they are transplante...
Detailed Description
Bone marrow and blood samples from both non-sensitized kidney transplant recipients and sensitized kidney transplant recipients will be collected. The samples will be used to compare the effect immuno...
Eligibility Criteria
Inclusion
- Participants must be between the ages of 18 and 70 years of age and undergoing a kidney transplant.
Exclusion
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00275717
Start Date
March 1 2005
End Date
December 1 2010
Last Update
December 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905